1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10831)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22057)
  2. Department of Medicine (22035)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5184)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22057)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B-Southwest Oncology Group 80702 (Alliance)
    Journal Article

    Brown, J. C.; Ma, C.; Shi, Q.; Couture, F.; Kuebler, P.; Kumar, P.; Tan, B.; Krishnamurthi, S.; Chang, V.; Goldberg, R. M.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment
    Journal Article

    Smith, E. A.; Belote, R. L.; Cruz, N. M.; Moustafa, T. E.; Becker, C. A.; Jiang, A.; Alizada, S.; Prokofyeva, A.; Chan, T. Y.; Seasor, T. A.; more...
    Journal of Experimental and Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • KRAS variants are associated with survival outcomes and genomic alterations in biliary tract cancers
    Journal Article

    Gelfer, R.; Gulla, A.; Kalvin, H. L.; Song, Y.; Harding, J.; Abou-Alfa, G. K.; O'Reilly, E. M.; Park, W.; Chandwani, R.; Wei, A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Waiting to exhale: The feasibility and appropriateness of home blood oxygen monitoring in oncology patients post–hospital discharge
    Journal Article

    Liu, S. Y.; Doshi, S. D.; Ebstein, A. M.; Holland, J.; Sapir, A.; Leung, M.; Huang, J.; Fahy, R.; Salvaggio, R.; Begue, A.; more...
    JCO Clinical Cancer Informatics (2024)

    Fulltext@MSK | Save
  • Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: Results from the open-label, randomised, phase II FRACTION-RCC trial
    Journal Article

    Choueiri, T. K.; Kuzel, T. M.; Tykodi, S. S.; Verzoni, E.; Kluger, H.; Nair, S.; Perets, R.; George, S.; Gurney, H.; Pachynski, R. K.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save
  • Atezolizumab monotherapy for metastatic urothelial carcinoma: Final analysis from the phase II IMvigor210 trial
    Journal Article

    Rosenberg, J. E.; Galsky, M. D.; Powles, T.; Petrylak, D. P.; Bellmunt, J.; Loriot, Y.; Necchi, A.; Hoffman-Censits, J.; Perez-Gracia, J. L.; van der Heijden, M. S.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save
  • A phase I dose-escalation study of LRP5/6 antagonist BI 905677 in patients with advanced solid tumors
    Journal Article

    Lenz, H. J.; Argilés, G.; de Jonge, M. J. A.; Yaeger, R.; Doi, T.; El-Khoueiry, A.; Eskens, F.; Kuboki, Y.; Bertulis, J.; Nazabadioko, S.; more...
    ESMO Open (2024)

    Fulltext@MSK | Save
  • Genotype-directed synthetic cytotoxicity of ATR inhibition with radiotherapy
    Journal Article

    Ng, V.; Sinha, S.; Novaj, A.; Ma, J.; McDermott, N.; Pei, X.; Longhini, A. L. F.; Grimsley, H.; Gardner, R.; Rosen, E.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Histology-specific clinical trial of lenvatinib and pembrolizumab in patients with sarcoma
    Journal Article

    Movva, S.; Seier, K.; Avutu, V.; Banks, L. B.; Chan, J.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • The use of zenocutuzumab for NRG1 fusion–positive tumors [Interview]
    Miscellaneous

    Schram, A.
    Clinical Advances in Hematology & Oncology (2024)

    Fulltext@MSK | Save